Bicara Therapeutics BCAX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period at other companies

RepligenRGEN

0—

HNIHNI

42K-96.2%

First Busey CorporationBUSE

5.3K—

TRV

Trevi Therapeutics, Inc.TRVI

105K-63.8%

HCI GroupHCI

20K—

SkyWestSKYW

3.8K-60.8%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's share-based compensation arrangement by share-based payment award, options, exercises in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's share-based compensation arrangement by share-based payment award, options, exercises in period?: Bicara Therapeutics (BCAX) reported share-based compensation arrangement by share-based payment award, options, exercises in period of 366.4K in Q1 2026.
What does share-based compensation arrangement by share-based payment award, options, exercises in period mean?: The number of common shares issued as a result of employees exercising their vested stock options. This activity directly impacts the total weighted-average shares outstanding and reflects the conversion of incentive compensation into equity ownership.